|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2006-11-19
|
|
pubmed:abstractText |
Uncertainty regarding relationships of antidepressant treatment and suicidality encouraged systematic review of data on suicidal behaviors and ideation from Phase II and III clinical trials of duloxetine for major depressive disorder (MDD).
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0271-0749
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
26
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
587-94
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:17110815-Adult,
pubmed-meshheading:17110815-Antidepressive Agents,
pubmed-meshheading:17110815-Clinical Trials, Phase II as Topic,
pubmed-meshheading:17110815-Clinical Trials, Phase III as Topic,
pubmed-meshheading:17110815-Depressive Disorder, Major,
pubmed-meshheading:17110815-Double-Blind Method,
pubmed-meshheading:17110815-Female,
pubmed-meshheading:17110815-Humans,
pubmed-meshheading:17110815-Incidence,
pubmed-meshheading:17110815-Male,
pubmed-meshheading:17110815-Psychiatric Status Rating Scales,
pubmed-meshheading:17110815-Randomized Controlled Trials as Topic,
pubmed-meshheading:17110815-Risk Assessment,
pubmed-meshheading:17110815-Risk Factors,
pubmed-meshheading:17110815-Suicide,
pubmed-meshheading:17110815-Thinking,
pubmed-meshheading:17110815-Thiophenes,
pubmed-meshheading:17110815-Time Factors
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Duloxetine: meta-analyses of suicidal behaviors and ideation in clinical trials for major depressive disorder.
|
|
pubmed:affiliation |
Eli Lilly Research Center, Indianapolis, IN 46285, USA. acharya_nayan@lilly.com
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Meta-Analysis
|
